Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunity Persistence After Abridged Intradermal Rabies PEP
NCT04829630Completed
- Sponsor
- Institut Pasteur
- Start
- Oct 2021
- Primary completion
- Feb 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
Open-label, single-arm trial of Rabies vaccine in rabies, sponsored by Institut Pasteur. Primary endpoint: Antibody titers measured (FAVN, RFFIT) and cellular immunity markers at 1 week. Started Oct 2021; status: completed.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT04829630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04829630.